Endometrial cancer
A cancer that starts in the lining of the womb, and usually happens after the menopause. The main sign is bleeding from the vagina after the menopause, between periods, or heavier than is normal for you. The most common treatment is surgery to remove the womb, sometimes with radiotherapy, chemotherapy or hormone medicine. Most cases are found early, before the cancer has spread, and these are usually cured.
Read more about endometrial cancerTrial-stage treatments and research studies you can join
Filters
- Tests relacorilant with other treatments for gynecological cancers
Tests relacorilant with other drugs in adults with ovarian or endometrial cancer.
Catania, ItalyAlso Milan, Pavia, Rome, Torino, TrevisoAge 18+ - Tests trastuzumab deruxtecan with immunotherapy for HER2-expressing endometrial cancer
Tests a HER2-targeted drug with immunotherapy as first treatment in adults with advanced endometrial cancer.
Catania, ItalyAlso Florence, Milan, Monza, Naples, Reggio Emilia, Rome, TurinAge 18+ - Tests GSK5460025 alone or combined with other drugs in solid tumors
Tests the pill GSK5460025 in adults with certain solid tumors that have specific genetic traits.
Milan, ItalyAge 18+ - Tests lighter follow-up treatment for early endometrial cancer with certain tumor gene profiles
Tests reduced treatment after surgery in adults with early endometrial cancer.
Brescia, ItalyAlso Florence, Lecco, Milan, RomeAge 18+ - Tests BNT323 or chemotherapy in people with recurring HER2-expressing uterine cancer
Compares BNT323 with chemotherapy in adults with recurring uterine cancer previously treated with immunotherapy.
Bari, ItalyAlso Bologna, Catania, Meldola, Milan, Modena, Naples, Perugia, Pisa, …Age 18+ - Tests sacituzumab tirumotecan with pembrolizumab in endometrial cancer
Tests sacituzumab tirumotecan plus pembrolizumab in adults with advanced endometrial cancer.
Catania, ItalyAlso Florence, Meldola, Milan, Naples, Pisa, Rome, TurinAge 18+ - Tests Sofe-M in adults with selected advanced solid tumors
Tests whether Sofe-M is safe and tolerable in adults with advanced solid tumors.
Milan, ItalyAge 18+ - Tests sevabertinib in solid tumors with HER2 gene mutations
Tests sevabertinib tablets in adults with solid tumors carrying HER2 mutations.
Milan, ItalyAlso Reggio Emilia, RomeAge 18+ - Compares Rina-S with standard chemotherapy in endometrial cancer
Tests Rina-S against standard chemotherapy in adults with recurrent endometrial cancer.
Bologna, ItalyAlso Catania, Meldola, Milan, Monza, Prato, Reggio EmiliaAge 18+ - EIK1005 alone or with pembrolizumab for advanced solid tumors
Tests EIK1005, alone and with pembrolizumab, in adults with advanced solid tumors.
Rome, ItalyAge 18+ - Tests trastuzumab deruxtecan after surgery for HER2-expressing endometrial cancer
Tests trastuzumab deruxtecan against standard chemotherapy in adults with HER2-expressing endometrial cancer.
Bari, ItalyAlso Bologna, Brescia, Florence, Lecco, Milan, Monza, Naples, Padova, …Age 18+ - Tests patritumab deruxtecan in adults with several advanced solid tumors
Tests patritumab deruxtecan in adults with advanced solid tumors, including melanoma and gastric cancer.
Bergamo, ItalyAlso Genova, Naples, VeronaAge 18+ - Tests ifinatamab deruxtecan in several types of recurrent or spreading solid tumors
Tests ifinatamab deruxtecan in adults with solid tumors that returned or spread.
Candiolo, ItalyAlso Milan, Naples, Rome, RozzanoAge 18+ - Tests AZD8205 alone or combined in advanced solid tumors
Tests a new drug, AZD8205, in adults with advanced solid tumors, alone or combined.
Milan, ItalyAlso Modena, RomaAge 18+ - Testing radiotherapy with durvalumab after surgery for mismatch-repair deficient endometrial cancer
Compares radiotherapy with durvalumab against radiotherapy with or without chemotherapy in endometrial cancer.
Rome, ItalyAge 18+ - Tests rezatapopt in advanced solid tumors with a TP53 Y220C mutation
Tests rezatapopt, alone or with pembrolizumab, in people with advanced TP53 Y220C tumors.
Candiolo, ItalyAlso Milan, Naples, Rome, RozzanoAge 12+ - Tests ubamatamab alone or with cemiplimab in recurrent ovarian and uterine cancers
Tests ubamatamab, alone or with cemiplimab, in adults with recurrent ovarian or uterine cancer.
Milan, ItalyAlso Naples, RomeAge 18+ - Tests datopotamab deruxtecan alone or combined with other drugs in advanced solid tumours
Tests datopotamab deruxtecan, alone or combined, in adults with advanced solid tumours.
Milan, ItalyAlso NaplesAge 18 to 130 - Tests elironrasib and daraxonrasib in advanced solid tumors with KRAS G12C mutation
Tests two drugs, alone and together, in adults with advanced KRAS G12C-mutated cancers.
Ancona, ItalyAlso Aviano, Meldola, Milan, Naples, Orbassano, Ravenna, VeronaAge 18+ - Tests BL-B01D1 in adults with advanced solid cancers including lung cancer
Tests the drug BL-B01D1 in adults with advanced lung and other solid cancers.
Candiolo, ItalyAlso RozzanoAge 18+
Trials that have ended are not listed here, because nobody can join them. Stopped and finished Endometrial cancer trials (research view)
Where treatment stands
Most people are found at an early stage, when this cancer is usually cured; once it has spread far, it is rarely cured.
Approved: 7
Officially approved for this disease in the EU, the US, Switzerland or France.
Human testing stage: 27
Being tested in people. Many treatments at this stage are never approved.
Animal testing stage: 2
Worked in animals in a study published in the last 12 months. Most treatments at this stage never reach people.
Lab research stage: 4
Worked on cells in the lab in a study published in the last 12 months. Most early ideas never reach people.
Placebo: a dummy treatment without the medicine, used for comparison.
Phase 1, 2, 3: the steps of testing in people. Phase 1 checks safety, phase 3 is the last step before approval.
The EU medicines agency (EMA) and its list of medicines in the EU, US prescribing labels (DailyMed, openFDA), the Swiss medicines register (Swissmedic), the French medicines database (ANSM) and the Health Canada drug database, checked on 11 November 2026. Every medicine links to its own official text.
A computer made this list from the official texts: it kept only medicines whose own approval text names the disease, wrote "Who it is for" from that text and checked it against the text a second time. People have not reviewed it yet.
The trials: ClinicalTrials.gov and the EU trials register, as copied into our trial database, checked on 12 November 2026. Every treatment in trials links to its own trial records; the texts are written by AI from them and checked against them by a second AI. People have not reviewed them yet. Placebo, standard medicines used for comparison and procedures are left out.
Phase 3 trials are listed from every country; only some phase 2 trials are listed, so 87 other open phase 2 trials are not listed.
Animal and lab research: studies listed in PubMed and published in the 12 months before 12 November 2026, found by a search for endometrial (womb) cancer. AI chose the treatments from the study summaries and wrote the texts; a second AI checked each one against its study summary. People have not reviewed them yet. Treatments already in the approved or human testing lists are left out. A result in animals or cells does not show that a treatment works in people.
Not medical advice. Talk to your doctor before you change any treatment.
The approval records under a medicine come from Drugs@FDA and the FDA labels (openFDA) and from the EU medicines agency’s medicine data, with its orphan designations, checked on 13 Nov 2026. A date is the medicine’s first approval, for any use; the quoted text is its approved use as written today.
Support organisations
Patient organisations and helplines in Italy, for you and your family.
Endometrial cancer organisations in Italy
- Lega Italiana per la Lotta contro i Tumori (LILT)
Italian national cancer league (ECL member) focused on prevention, early diagnosis and support for cancer patients through its provincial associations.
General support in Italy
- Telefono Amico Italia
Italian volunteer emotional support service since 1967, listening to anyone in crisis or loneliness by phone (02 2327 2327), chat and WhatsApp.
International organisations
Offer tissue or data
There are three ways to help research move faster.
Approved treatments
7 medicines are approved for endometrial cancer in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.
Checked on 11 Nov 2026 in the official lists of the US (FDA), the EU (EMA), Japan (PMDA, approvals since April 2004), Switzerland (Swissmedic), France (ANSM, medicines approved in France only) and Taiwan (TFDA). For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. 4 uncertain matches are left out. Other countries' own approvals were not checked.
“Miracle cure” fact checker
Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.
What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.
Before you pay for anything, ask three things
- Is there a published study in people?
- Can I have the full price in writing?
- What does my doctor say?
“Cures” others already fact-checked
- Ivermectin & Endometrial cancer
- Fenbendazole & Endometrial cancer
- CBD (cannabidiol) & Endometrial cancer
- Vitamin C (incl. high-dose) & Endometrial cancer
About endometrial cancer
Sources: NHS, NCI PDQ, MedlinePlus, NCI SEER
A cancer that starts in the lining of the womb, and usually happens after the menopause. The main sign is bleeding from the vagina after the menopause, between periods, or heavier than is normal for you. The most common treatment is surgery to remove the womb, sometimes with radiotherapy, chemotherapy or hormone medicine. Most cases are found early, before the cancer has spread, and these are usually cured.
What is it?
The womb (uterus) is where a baby grows during pregnancy. Endometrial cancer starts in the womb's lining, the endometrium. It is the most common kind of womb cancer. The cause is not known, but too much of the hormone oestrogen raises the risk.
It is most common in people who have been through the menopause, but anyone with a womb can get it. Being overweight, some kinds of hormone replacement therapy (HRT), diabetes, never having given birth, a late menopause and the breast cancer medicine tamoxifen raise the risk. It is more likely if close family have had womb, bowel or ovarian cancer, or with an inherited condition called Lynch syndrome. A healthy weight, regular exercise and a balanced diet can lower your chances.
The first signs
The most common sign is bleeding from the vagina that is not normal for you.
- bleeding or spotting after the menopause;
- heavy periods that are unusual for you, or bleeding between periods;
- a change in the discharge from your vagina;
- pain in the lower back or between the hips (pelvis), or pain during sex;
- a lump or swelling in your tummy, or peeing or pooing more or less often than usual.
How doctors find out
Your family doctor asks about your symptoms and may examine your tummy and vagina; you can ask for a female doctor or nurse. If cancer is possible, they send you to a specialist. You may have a scan with a small device placed in the vagina, blood tests, a look inside the womb with a thin camera (hysteroscopy), and a biopsy, where cells are taken from the womb lining. The tests can feel uncomfortable but should not hurt.
Results usually take a few weeks. If it is cancer, more scans (CT, MRI or PET) and genetic tests show how far it has spread. A specialist nurse is your main contact during and after treatment.
Current treatment
Surgery to remove the womb is the main treatment, sometimes followed by radiotherapy or chemotherapy to lower the chance of the cancer coming back; hormone therapy, immunotherapy or targeted medicines are used when it has spread or come back.
Will it get worse?
How serious it is depends on how big the cancer is, whether it has spread, and your general health. Irregular bleeding usually makes people see a doctor early, so most cases are found before the cancer has spread; about two in three are still only in the womb when found. Cancer that has spread to other parts of the body is rarely cured.
Medicines: what helps, and what to watch for
Chemotherapy uses medicines to kill cancer cells. It can be given after surgery to lower the chance of the cancer coming back, together with radiotherapy, or to slow the cancer and ease symptoms if it has spread. Hormone therapy blocks the hormones some of these cancers need to grow; it can help when the cancer has spread or you are not well enough for surgery or radiotherapy. Immunotherapy, which helps your immune system find and kill cancer cells, and targeted medicines may be options for advanced cancer or cancer that comes back.
Good to know:
- Common side effects of chemotherapy are tiredness, feeling sick, a sore mouth, hair loss for a while, and numbness or tingling in the hands or feet;
- Radiotherapy can cause tiredness, diarrhoea (which should go within a few weeks of treatment ending), vaginal dryness or narrowing, and the menopause;
- You do not need to wait for your next check-up to raise a side effect that worries you.
Radiotherapy, for some people
Radiotherapy uses high-energy rays to kill cancer cells. It can come from a machine outside the body or from a source placed inside, near the cancer. It may be given after surgery to lower the chance of the cancer coming back, and it can be the main treatment if you cannot have surgery. It can also ease symptoms.
Surgery, for some people
Surgery is the most common treatment, especially for early cancer. The surgeon removes the womb and the neck of the womb (cervix) in an operation called a hysterectomy. Sometimes the ovaries and fallopian tubes, nearby lymph nodes or the upper part of the vagina are removed too. If the cancer has spread or come back, surgery may also remove nearby parts, such as the ovaries and tubes, the bladder or the rectum. Recovery can take a long time. Your team will talk with you about what treatment means for having children.
Is there a cure?
Yes, often. When the cancer is found early and is only in the womb, treatment usually cures it. When it has spread far, it is rarely cured, and treatment aims to control it. Clinical trials are testing new treatments, and joining one may be an option for some people.
Median survival
About 3 years with chemotherapy for stage III or IV
Measured in: Stage III or IV, with chemotherapy: the GOG-0209 trial (1,381 women)
The figures behind it
NCI PDQ (health professional): in the GOG-0209 trial (1,381 women), median overall survival was 37 months with carboplatin plus paclitaxel and 41 months with paclitaxel, doxorubicin and cisplatin; in advanced or recurrent cancer after earlier platinum treatment, it was 18.7 months with pembrolizumab plus lenvatinib vs 11.9 months with chemotherapy (KEYNOTE-775). Most cases are found early, and localized disease is usually cured.
Sources
Written in plain words by Frontlight from these pages:
- NHS: Womb (uterus) cancer – Overview
- NHS: Womb (uterus) cancer – Symptoms
- MedlinePlus: Uterine Cancer
- NCI PDQ: Endometrial Cancer Treatment (PDQ) – Health Professional Version
- NHS: Womb (uterus) cancer – Causes
- NHS: Womb (uterus) cancer – Tests and next steps
- NCI SEER: Cancer Stat Facts: Uterine Cancer
- NHS: Womb (uterus) cancer – Treatment
- NCI PDQ: Endometrial Cancer Treatment (PDQ) – Patient Version
- NHS: Chemotherapy – Side effects
- NHS: Radiotherapy – Side effects